SYNTAX-justified trend toward restricting coronary artery bypass grafting to more serious cases
- PMID: 24338621
- DOI: 10.1007/s11748-013-0360-z
SYNTAX-justified trend toward restricting coronary artery bypass grafting to more serious cases
Abstract
Objective: Since drug-eluting stents (DESs) appeared in Japan, coronary artery bypass grafting (CABG) has been indicated for more severe lesions. To understand the implications of this trend, we compared SYNTAX scores in two groups of patients treated with CABG before and after DESs approval.
Methods: Consecutive CABG patients during January 2001-July 2003 (pre-DES era patients, n = 160) and January 2008-July 2010 (DES era patients, n = 103) were included. The SYNTAX scores of both groups were compared and a cardiologist retrospectively re-evaluated coronary angiograms to determine whether CABG or percutaneous coronary intervention (PCI) would be recommended under current standards.
Results: SYNTAX scores were significantly higher in DES era group compared with pre-DES era group (33.3 ± 10.6 vs. 28.1 ± 10.6, p < 0.01). Percutaneous coronary intervention would be the preferred treatment option in 66 (41 %) of pre-DES patients, whose SYNTAX scores were significantly lower than those of patients who were considered good candidates for CABG (21.9 ± 9.3 vs. 32.5 ± 9.1, p < 0.01).
Conclusions: Although CABG is now being performed in intermediate-to-highly complex cases, DES era outcomes, including operative mortality and early graft failure, have not worsened in comparison to the pre-DES era.
Similar articles
-
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5. Lancet. 2013. PMID: 23439102 Clinical Trial.
-
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001. JACC Cardiovasc Interv. 2009. PMID: 19628183
-
Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.Int J Cardiol. 2015;189:153-8. doi: 10.1016/j.ijcard.2015.04.059. Epub 2015 Apr 9. Int J Cardiol. 2015. PMID: 25897895
-
Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):347-54. doi: 10.1093/icvts/ivt509. Epub 2013 Dec 16. Interact Cardiovasc Thorac Surg. 2014. PMID: 24345688 Free PMC article. Review.
-
Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.Cardiovasc Revasc Med. 2015 Mar;16(2):70-7. doi: 10.1016/j.carrev.2015.01.002. Epub 2015 Jan 22. Cardiovasc Revasc Med. 2015. PMID: 25662779 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous